VenUS II: A randomised controlled trial of larval therapy in the management of leg ulcers

Health Technology Assessment

Volumn 13, Issue 55, 2009, Pages 1-182

  Dumville, J C ^a   Worthy, G ^a   Soares, M O ^a   Bland, J M ^a   Cullum, N ^a   Dowson, C ^b   Iglesias, C ^a   McCaughan, D ^a   Mitchell, J L ^c   Nelson, E A ^d   Torgerson, D J ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c Micropathology Ltd   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ANKLE BRACHIAL INDEX; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIOLOGY; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMMUNITY CARE; COMMUNITY HEALTH NURSING; COMPRESSION BANDAGE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEBRIDEMENT; DISEASE DURATION; ECONOMIC EVALUATION; FEMALE; HEALTH CARE COST; HUMAN; HYDROGEL; HYDROGEL DRESSING; LARVA; LEG ULCER; MAGGOT THERAPY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTICENTER STUDY; PAIN; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RURAL POPULATION; SKIN NECROSIS; SURGICAL TECHNIQUE; SWAMP; TREATMENT DURATION; TREATMENT OUTCOME; URBAN POPULATION; WOUND DRESSING; WOUND HEALING;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANIMALS; COST-BENEFIT ANALYSIS; DEBRIDEMENT; DIPTERA; FEMALE; GREAT BRITAIN; HUMANS; HYDROGEL; LARVA; LEG ULCER; MALE; MIDDLE AGED; TREATMENT OUTCOME; WOUND HEALING; YOUNG ADULT;

EID: 74849101832     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta13550     Document Type: Article

References (148)

1. Margolis DJ, Bilker W, Santanna J, Baumgarten M. Venous leg ulcer: incidence and prevalence in the elderly. J Am Acad Dermatol 2002;46:381-6.
2. Royal College of Nursing. The Nursing Management of Venous Leg Ulcers. London: Royal College of Nursing; 2006.
3. Vowden K, Vowden P. Mixed aetiology ulcers. J Wound Care 2001;10:520.
4. Simon DA, Freak L, Williams IM, McCollum CN. Progression of arterial disease in patients with healed venous ulcers. J Wound Care 1994;3:179-80.
5. Humphreys ML, Stewart AHR, Gohel MS, Taylor M, Whyman MR, Poskitt KR. Management of mixed arterial and venous leg ulcers. Br J Surg 2007;94:1104-7.
6. Cornwall JV, Dore CJ, Lewis JD. Leg ulcers: epidemiology and aetiology. Br J Surg 1986;73:693-6.
7. Nelzen O, Bergqvist D, Lindhagen A. Venous and non-venous leg ulcers: clinical history and appearance in a population study. Br J Surg 1994;81:182-7.
8. Herber OR, Schnepp W, Rieger MA. A systematic review on the impact of leg ulceration on patients' quality of life. Health Qual Life Outcomes 2007;5:44.
9. Hofman D, Ryan TJ, Arnold F, Cherry GW, Lindholm C, Bjellerup M, et al. Pain in venous leg ulcers. J Wound Care 1997;6:222-4.
10. Hareendran A, Bradbury A, Budd J, Geroulakos G, Hobbs R, Kenkre J, et al. Measuring the impact of venous leg ulcers on quality of life. J Wound Care 2005;14:53-7.
11. Nelzen O, Bergqvist D, Lindhagen A. Long-term prognosis for patients with chronic leg ulcers: a prospective cohort study. Eur J Vasc Endovasc Sur 1997;13:500-8.
12. Iglesias C, Nelson EA, Cullum NA, Torgerson DJ, on behalf of the VenUS Team. VenUS I: a randomised controlled trial of two types of bandage for treating venous leg ulcers. Health Technol Assess 2004;8:iii.
13. Department of Health. Prescription Cost Analysis Data England. London: Department of Health; 2006.
14. Hickie S, Ross S, Bond C. A survey of the management of leg ulcers in primary care settings in Scotland. J Clin Nurs 1998;7:45-50.
15. Callam MJ, Ruckley CV, Harper DR, Dale JJ. Chronic ulceration of the leg: extent of the problem and provision of care. BMJ 1985;290:1855-6.
16. Palfreyman S, Nelson EA, Michaels JA. Dressings for venous leg ulcers: systematic review and metaanalysis. BMJ 2007;335:244-255.
17. Cullum N, Nelson EA, Flemming K, Sheldon T. Systematic reviews of wound care management: (5) beds; (6) compression; (7) laser therapy, therapeutic ultrasound, electrotherapy and electromagnetic therapy. Health Technol Assess 2001;5:1-221.
18. Cullum N, Nelson EA, Fletcher AW, Sheldon TA. Compression for venous leg ulcers.[update of Cochrane Database Syst Rev 2000;(3):CD000265; PMID: 10908469]. Cochrane Database Syst Rev 2001;CD000265.
19. Scottish Intercollegiate Guidelines Network. The care of patients with chronic leg ulcers. Edinburgh: SIGN Secretariat, 1998.
20. O'Meara S, Tierney, J, Cullum N, Bland M, Cooper P, Franks P. Four-layer compression bandage compared with short-stretch bandage for venous leg ulcers: a meta-analysis of randomised controlled trials using individual patient data (IPD). 17th Annual Meeting of the European Tissue Repair Society. Southampton, UK, 2007.
21. Armstrong DG, Mossel J, Short B, Nixon BP, Knowles EA, Boulton AJM. Maggot debridement therapy: a primer. J Am Podiatr Med Assoc 2002;92:398-401.
22. O'Brien M. Exploring methods of wound debridement. Br J Community Nurs 2002;12(Suppl):10-18.
23. Robson MC, Cooper DM, Aslam R, Gould LJ, Harding KG, Margolis DJ, et al. Guidelines for the treatment of venous ulcers. Wound Repair Regen 2006;14:649-62.
24. Bradley M, Cullum N, Sheldon T. The debridement of chronic wounds: a systematic review. Health Technol Assess 3(17), part 1.
25. Chan DCW, Fong DHF, Leung JYY, Patil NG, Leung GKK. Maggot debridement therapy in chronic wound care. Hong Kong Med J 2007;13:382-6.
26. Sherman RA, Hall MJ, Thomas S. Medicinal maggots: an ancient remedy for some contemporary afflictions. Annu Rev Entomol 2000;45:55-81.
27. Baer W. The treatment of chronic osteomyelitis with the maggot (larva of the blow fly). J Bone Joint Sur 1931;13:438-75.
28. Thomas S. The use of sterile maggots in wound management. Nurs Times 2002;98:45-6.
29. MacDougall KM, Rodgers FRT. A case study using larval therapy in the community setting. Br J Nurs 2004;13:255-60.
30. Richardson M. The benefits of larval therapy in wound care. Nurs Stand 2004;19:70.
31. Sherman R. Age-old therapy gets new approval. Adv Skin Wound Care 2005;18:12-15.
32. Thomas S, McCubbin P. Use of maggots in the care of wounds. Hosp Pharmacist 2002;9:267-71.
33. Chambers L, Woodrow S, Brown AP, Harris PD, Phillips D, Hall M, et al. Degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia sericata used for the clinical debridement of non-healing wounds. Br J Dermatol 2003;148:14-23.
34. Thomas S, Jones M, Shutler S, Jones S. Using larvae in modern wound management. J Wound Care 1996;5:60-9.
35. Mumcuoglu KY, Miller J, Mumcuoglu M, Friger M, Tarshis M. Destruction of bacteria in the digestive tract of the maggot of Lucilia sericata (Diptera: Calliphoridae). J Med Entomol 2001;38:161-6.
36. Bexfield A, Nigam Y, Thomas S, Ratcliffe NA. Detection and partial characterisation of two antibacterial factors from the excretions/secretions of the medicinal maggot Lucilia sericata and their activity against meticillin-resistant Staphylococcus aureus (MRSA). Microbes Infect 2004;6:1297-304.
37. Huberman L, Gollop N, Mumcuoglu KY, Block C, Galun R. Antibacterial properties of whole body extracts and haemolymph of Lucilia sericata maggots. J Wound Care 2007;16:123-7.
38. Huberman L, Gollop N, Mumcuoglu KY, Breuer E, Bhusare SR, Shai Y, et al. Antibacterial substances of low molecular weight isolated from the blowfly, Lucilia sericata. Med Vet Entomol 2007;21:127-31.
39. Thomas S, Andrews AM, Hay NP, Bourgoise S. The anti-microbial activity of maggot secretions: results of a preliminary study. J Tissue Viability 1999;9:127-32.
40. van der Plas MJA, Jukema GN, Wai S-W, Dogterom-Ballering HCM, Lagendijk EL, van Gulpen C, et al. Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother 2008;61:117-22.
41. Horn KL, Cobb AH, Jr., Gates GA. Maggot therapy for subacute mastoiditis. Arch Otolaryngol 1976;102:377-9.
42. Robinson W. Ammonium bicarbonate secreted by surgical maggots stimulates healing in purulent wounds. Am J Surg 1940;47:111-15.
43. Prete PE. Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy. Life Sci 1997;60:505-10.
44. van der Plas MJA, van der Does AM, Baldry M, Dogterom-Ballering HCM, van Gulpen C, van Dissel JT, et al. Maggot excretions/secretions inhibit multiple neutrophil pro-inflammatory responses. Microbes Infect 2007;9:507-14.
45. Horobin AJ, Shakesheff KM, Pritchard DI. Promotion of human dermal fibroblast migration, matrix remodelling and modification of fibroblast morphology within a novel 3D model by Lucilia sericata larval secretions. J Invest Dermatol 2006;126:1410-18.
46. Horobin AJ, Shakesheff KM, Pritchard DI. Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon the migration of human dermal fibroblasts over a fibronectin-coated surface. Wound Repair Regen 2005;13:422-33.
47. Petherick ES, O'Meara S, Spilsbury K, Iglesias CP, Nelson EA, Torgerson DJ. Patient acceptability of larval therapy for leg ulcer treatment: a randomised survey to inform the sample size calculation of a randomised trial. BMC Med Res Methodol 2006;6:43.
48. Steenvoorde P, Buddingh TJ, van Engeland A, Oskam J. Maggot therapy and the "yuk" factor: an issue for the patient? Wound Repair Regen 2005;13:350-2.
49. Thomas S, Wynn K, Fowler T, Jones M. The effect of containment on the properties of sterile maggots. Br J Nurs 2002;11(Suppl): S21-2.
50. Blake FAS, Abromeit N, Bubenheim M, Li L, Schmelzle R. The biosurgical wound debridement: experimental investigation of efficiency and practicability. Wound Repair Regen 2007;15:756-61.
51. Steenvoorde P, Jacobi CE, Oskam J. Maggot debridement therapy: free-range or contained? An in-vivo study. Adv Skin Wound Care 2005;18:430- 5.
52. Wolff H, Hansson C. Larval therapy - an effective method of ulcer debridement. Clin Exp Dermatol 2003;28:134-7.
53. Tantawi TI, Gohar YM, Kotb MM, Beshara FM, El-Naggar MM. Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers. J Wound Care 2007;16:379-83.
54. Wollina U, Liebold K, Schmidt W-D, Hartmann M, Fassler D. Biosurgery supports granulation and debridement in chronic wounds - clinical data and remittance spectroscopy measurement. Int J Dermatol 2002;41:635-9.
55. Courtenay M, Church JC, Ryan TJ. Larva therapy in wound management. J R Soc Med 2000;93:72-4.
56. Sherman RA. Maggot versus conservative debridement therapy for the treatment of pressure ulcers. Wound Repair Regen 2002;10:208-14.
57. Wayman J, Nirojogi V, Walker A, Sowinski A, Walker MA. The cost effectiveness of larval therapy in venous ulcers. J Tissue Viability 2000;10:91-4.
58. Krizek T, Robson, MC, Kho E. Bacterial growth and skin graft survival. Surgical Forum 1967;18:518.
59. Robson M, Lea, CE, Dalton JB, Heggers JP. Quantitative bacteriology and delayed wound closure. Surgical Forum 1968;19:501-2.
60. Robson MC, Stenberg BD, Heggers JP. Wound healing alterations caused by infection. Clin Plast Surg 1990;17:485-92.
61. Browne AC, Vearncombe M, Sibbald RG. High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of DERMAGRAFT. Ostomy Wound Manage 2001 47:44-9.
62. Bendy RH, Jr., Nuccio PA, Wolfe E, Collins B, Tamburro C, Glass W, et al. Relationship of quantitative wound bacterial counts to healing of decubiti: effect of topical gentamicin. Antimicrob Agents Chemother 1964;10:147-55.
63. Robson MC, Heggers JP. Bacterial quantification of open wounds. Mil Med 1969;134:19-24.
64. Sibbald RG, Browne AC, Coutts P, Queen D. Screening evaluation of an ionized nanocrystalline silver dressing in chronic wound care. Ostomy Wound Manage 2001;47:38-43.
65. Bowler PG. The 10(5) bacterial growth guideline: reassessing its clinical relevance in wound healing. Ostomy Wound Manage 2003;49:44-50.
66. Trengove NJ, Stacey MC, McGechie DF, Mata S. Qualitative bacteriology and leg ulcer healing. J Wound Care 1996;5:277-80.
67. Wall IB, Davies CE, Hill KE, Wilson MJ, Stephens P, Harding KG, et al. Potential role of anaerobic cocci in impaired human wound healing. Wound Repair Regen 2002;10:346-53.
68. Davies CE, Hill KE, Newcombe RG, Stephens P, Wilson MJ, Harding KG, et al. A prospective study of the microbiology of chronic venous leg ulcers to reevaluate the clinical predictive value of tissue biopsies and swabs. Wound Repair Regen 2007;15:17-22.
69. Bowler PG, Davies BJ. The microbiology of infected and non-infected leg ulcers. Int J Dermatol 1999;38:573-8.
70. Penhallow K. A review of studies that examine the impact of infection on the normal wound-healing process. J Wound Care 2005;14:123-6.
71. Halbert AR, Stacey MC, Rohr JB, Jopp-McKay A. The effect of bacterial colonization on venous ulcer healing. Australas J Dermatol 1992;33:75-80.
72. Hansson C, Hoborn J, Moller A, Swanbeck G. The microbial flora in venous leg ulcers without clinical signs of infection. Repeated culture using a validated standardised microbiological technique. Acta Derm Venereol 1995;75:24-30.
73. O'Meara S, Al-Kurdi D, Ovington LG. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database of Systematic Reviews 2008;CD003557.
74. Alinovi A, Bassissi P, Pini M. Systemic administration of antibiotics in the management of venous ulcers. A randomized clinical trial. J Am Acad Dermatol 1986;15:186-91.
75. Huovinen S, Kotilainen P, Jarvinen H, Malanin K, Sarna S, Helander I, et al. Comparison of ciprofloxacin or trimethoprim therapy for venous leg ulcers: results of a pilot study. J Am Acad Dermatol 1994;31:279-81.
76. Eriksson G, Eklund AE, Kallings LO. The clinical significance of bacterial growth in venous leg ulcers. Scand J Infect Dis 1984;16:175-80.
77. Grundmann H, Tami A, Hori S, Halwani M, Slack R. Nottingham Staphylococcus aureus population study: prevalence of MRSA among elderly people in the community. BMJ 2002;324:1365-6.
78. Warshawsky B, Hussain Z, Gregson DB, Alder R, Austin M, Bruckschwaiger D, et al. Hospital- and community-based surveillance of meticillin-resistant Staphylococcus aureus: previous hospitalization is the major risk factor. Infect Control Hosp Epidemiol 2000;21:724- 7.
79. Tentolouris N, Petrikkos G, Vallianou N, Zachos C, Daikos GL, Tsapogas P, et al. Prevalence of meticillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect 2006;12:186-9.
80. Lecornet E, Robert J, Jacqueminet S, Van Georges H, Jeanne S, Bouilloud F, et al. Preemptive isolation to prevent meticillin-resistant Staphylococcus aureus cross-transmission in diabetic foot. Diabetes Care 2007;30:2341-2.
81. Steenvoorde P, Jukema GN. The antimicrobial activity of maggots: in-vivo results. J Tissue Viability 2004;14:97-101.
82. Bowling FL, Salgami EV, Boulton AJM. Larval therapy: a novel treatment in eliminating meticillinresistant Staphylococcus aureus from diabetic foot ulcers. Diabetes Care 2007;30:370-1.
83. Kitching M. Patients' perceptions and experiences of larval therapy. J Wound Care 2004;13:25-9.
84. Vowden KR, Goulding V, Vowden P. Hand-held doppler assessment for peripheral arterial disease. J Wound Care 1996;5:125-8.
85. Margolis DJ, Berlin JA, Strom BL. Risk factors associated with the failure of a venous leg ulcer to heal. Arch Dermatol 1999;135:920- 6.
86. Margolis DJ, Berlin JA, Strom BL. Which venous leg ulcers will heal with limb compression bandages? Am J Med 2000;109:15-19.
87. Taylor R. 'Mouseyes': an aid to wound measurement using a computer. J Wound Care 1997;6:123-6.
88. Callum M. Prevalence of chronic leg ulceration and severe chronic venous disease in western countries. Phlebology 1992;1(Suppl):6-12.
89. Skene AI, Smith JM, Dore CJ, Charlett A, Lewis JD. Venous leg ulcers: a prognostic index to predict time to healing. BMJ 1992;305:1119-21.
90. Jenkinson C, Layte R. Development and testing of the UK SF-12 (short form health survey). J Health Serv Res Policy 1997;2:14-18.
91. Kind PT. The EuroQol instrument: an index of health-related quality of life. In Spilker B, editor. Quality of Life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven, 1996.
92. Schabereiter-Gurtner C, Maca S, Rolleke S, Nigl K, Lukas J, Hirschl A, et al. 16S rDNA-based identification of bacteria from conjunctival swabs by PCR and DGGE fingerprinting. Invest Ophthalmol Vis Sci 2001;42:1164-71.
93. Weisburg WG, Barns SM, Pelletier DA, Lane DJ. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 1991;173:697- 703.
94. Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 1992;327:293-301.
95. Cuny C, Witte W. PCR for the identification of meticillin-resistant Staphylococcus aureus (MRSA) strains using a single primer pair specific for SCCmec elements and the neighbouring chromosome-borne orfX. Clin Microbiol Infect 2005;11:834-7.
96. Iglesias CP, Birks Y, Nelson EA, Scanlon E, Cullum NA. Quality of life of people with venous leg ulcers: a comparison of the discriminative and responsive characteristics of two generic and a disease specific instruments. Qual Life Res 2005;14:1705-18.
97. Iglesias CP, Birks YF, Torgerson DJ. Increasing response rates to postal questionnaires. Changing layout of questionnaires increases response rates. BMJ 2002;325:444.
98. Edwards P, Roberts I, Clarke M, DiGuiseppi C, Pratap S, Wentz R, et al. Methods to increase response rates to postal questionnaires. Cochrane Database of Systematic Reviews 2007;MR000008.
99. Majeske C. Reliability of wound surface area measurements. Phys Ther 1992;72:138-41.
100. Briggs M. The prevalence of pain in chronic wounds and nurses' awareness of the problem. Br J Community Nurs 2006;15:5-9.
101. Briggs M, Bennett MI, Closs SJ, Cocks K. Painful leg ulceration: a prospective, longitudinal cohort study. Wound Repair Regen 2007;15:186-91.
102. Briggs M, Closs SJ. Patients' perceptions of the impact of treatments and products on their experience of leg ulcer pain. J Wound Care 2006;15:333-7.
103. Nemeth KA, Harrison MB, Graham ID, Burke S. Understanding venous leg ulcer pain: results of a longitudinal study. Ostomy Wound Manage 2004;50:34-46.
104. Nemeth KA, Harrison MB, Graham ID, Burke S. Pain in pure and mixed aetiology venous leg ulcers: a three-phase point prevalence study. J Wound Care 2003;12:336-40.
105. Steenvoorde P, Budding T, Oskam J. Determining pain levels in patients treated with maggot debridement therapy. J Wound Care 2005;14:485-8.
106. Green J, Thorogood N. Qualitative methods for health research. London: Sage, 2004.
107. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990;300:230-5.
108. National Institute of Health and Clinical Excellence. NICE technical guidance for manufacturers and sponsors on making a submission to a technology appraisal. London: NICE, March 2001.
109. Gardiner JC, Luo Z, Bradley CJ, Sirbu CM, Given CW. A dynamic model for estimating changes in health status and costs. Stat Med 2006;25:3648-67.
110. Pullenayegum EM, Willan AR. Semi-parametric regression models for cost-effectiveness analysis: improving the efficiency of estimation from censored data. Stat Med 2007;26:3274-3299.
111. Zhao H, Tsiatis AA. A consistent estimator for the distribution of quality adjusted survival time. Biometrika 1997;84:339-48.
112. Lin DY. Linear regression analysis of censored medical costs. Biostatistics 2000;1:35-47.
113. Willan AR, Lin DY, Manca A. Regression methods for cost-effectiveness analysis with censored data. Stat Med 2005;24:131-45.
114. Willan AR, Lin DY, Cook RJ, Chen EB. Using inverse-weighting in cost-effectiveness analysis with censored data. Stat Methods Med Res 2002;11:539-51.
115. Zucker D. Restricted mean life with covariates: modification and extension of a useful survival analysis method. J Am Stat Assoc 1998;93:702-9.
116. Karrison T. Restricted mean life with adjustment for covariates. J Am Stat Assoc 1987;82:1169-76.
117. Neymark N, Adriaenssen I, Gorlia T, Caleo S, Bolla M. Estimating survival gain for economic evaluations with survival time as principal endpoint: a cost-effectiveness analysis of adding early hormonal therapy to radiotherapy in patients with locally advanced prostate cancer. Health Econ 2002;11:233-48.
118. Dolan P, Gudex, C, Kind, P,Williams, A. A social tariff for EuroQol: results from a UK general population survey. University of York Centre for Health Economics Discussion Paper Series (no 138). York: Centre for Health Economics, 1995.
119. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005;14:487-96.
120. Lin DY, Feuer EJ, Etzioni R, Wax Y. Estimating medical costs from incomplete follow-up data. Biometrics 1997;53:419-34.
121. Raikou M, McGuire A. Estimating costs for economic evaluation. In: Jones AM, editor. The Elgar Companion to Health Economics. Cheltenham: Edward Elgar Publishing; 2006.
122. British Medical Association and Royal Pharmaceutical Society of Great Britain. British national formulary. London: BMA and RPS; 2006.
123. Curtis L NA. Unit costs of health and social care: Personal Social Services Research Unit. Canterbury: University of Kent, 2006.
124. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 1999;18:341-64.
125. Efron B, Tibshirani R.J. An introduction to the bootstrap. London: Chapman and Hall, 1993.
126. Briggs A, Fenn P. Trying to do better than average: a commentary on 'statistical inference for cost-effectiveness ratios'. Health Econ 1997;6:491-5.
127. Briggs AH, Gray AM. Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess 1999;3:1-134.
128. Laska EM, Meisner M, Siegel C. Statistical inference for cost-effectiveness ratios. Health Econ 1997;6:229-42.
129. Fenwick E, O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions. Health Econ 2004;13:405-15.
130. Department of Health. UK - NHS reference costs 2004. London: Department of Health; 2004.
131. Coffey A, Atkinson P. Making sense of qualitative data. London: Sage; 1996.
132. Pope C, Mays N. Qualitative research in health care. London: BMJ; 2006.
133. Ware J, E., Koninski, M.. SF-36. Physical and mental health summary scores: a manual for users of version 1.2. Lincoln, Rhode Island: Qualitymetric; 2001.
134. Steenvoorde P, Jacobi CE, Oskam J, Armstrong DG. Maggot therapy in "lower-extremity hospice" wound care. J Am Podiatr Med Assoc 2006;96:82-3.
135. Daeschlein G, Mumcuoglu KY, Assadian O, Hoffmeister B, Kramer A. In vitro antibacterial activity of maggot secretions. Skin Pharmacol Physiol 2007:20:112-15.
136. Bill TJ, Ratliff CR, Donovan AM, Knox LK, Morgan RF, Rodeheaver GT. Quantitative swab culture versus tissue biopsy: a comparison in chronic wounds. Ostomy Wound Manage 2001;47:34-7.
137. Gardner SE, Frantz RA, Saltzman CL, Hillis SL, Park H, Scherubel M. Diagnostic validity of three swab techniques for identifying chronic wound infection. Wound Repair Regen 2006;14:548-57.
138. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
139. Davies CE, Wilson MJ, Hill KE, Stephens P, Hill CM, Harding KG, et al. Use of molecular techniques to study microbial diversity in the skin: chronic wounds reevaluated. Wound Repair Regen 2001;9:332-40.
140. Roghmann MC, Siddiqui A, Plaisance K, Standiford H. MRSA colonization and the risk of MRSA bacteraemia in hospitalized patients with chronic ulcers. J Hosp Infect 2001;47:98-103.
141. Sculpher MJ, Claxton K, Drummond M, McCabe C. Whither trial-based economic evaluation for health care decision making? Health Econ 2006;15:677-87.
142. Spilsbury K, Cullum N, Dumville, JC, O'Meara, S, Petherick, ES, Thompson, C. Exploring patient perceptions of larval therapy as a potential treatment for venous leg ulceration. Health Expectations 2008;11:148-59.
143. Schultz GS, Sibbald RG, Falanga V, Ayello EA, Dowsett C, Harding K, et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen 2003;11(Suppl): S1-28.
144. Williams D, Enoch S, Miller D, Harris K, Price P, Harding KG. Effect of sharp debridement using curette on recalcitrant non-healing venous leg ulcers: a concurrently controlled, prospective cohort study. Wound Repair Regen 2005;13:131-7.
145. Steed DL, Donohoe D, Webster MW, Lindsley L. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J Am Coll Sur 1996;183:61-4.
146. Sherman RA, Pechter EA. Maggot therapy: a review of the therapeutic applications of fly larvae in human medicine, especially for treating osteomyelitis. Med Vet Entomol 1988;2:225-30.
147. Horobin AJ, Shakesheff KM, Woodrow S, Robinson C, Pritchard DI. Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon interactions between human dermal fibroblasts and extracellular matrix components. Br J Dermatol 2003;148:923-33.
148. Reynolds T, Russell L, Deeth M, Jones H, Birchall L. A randomised controlled trial comparing Drawtex with standard dressings for exuding wounds. J Wound Care 2004;13:71-4.